small molecule

NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE

DIPHENHYDRAMINE HYDROCHLORIDE; NAPROXEN SODIUM

Loss of exclusivity—loss of exclusivity
CompanyAmneal Pharmaceuticals →See this company's full patent-cliff portfolio

Drug detail

Brand nameNAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE
Active ingredientDIPHENHYDRAMINE HYDROCHLORIDE; NAPROXEN SODIUM
Strength25MG;220MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalOctober 2018
Marketing statusDISCN

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.